Stamibio Serum Dermocosmetic serum Italy - English - myHealthbox

stamibio serum dermocosmetic serum

guna - roe extract, high molecular weight hyaluronic acid, inositol, hop extract, cocoa extract, ginseng, guaranÀ,lotus extract, hydrolyzed dna and rna, maca extract, trace elements, anti-spot complex - serum - aqua/water, dimethicone, decyl oleate, glycerin, butylene glycol, dipropylene glycol, bis-peg/ppg-16/16 peg/ppg-16/16 dimethicone, saccharomyces/copper ferment, saccharomyces ferment, saccharomyces/magnesium ferment, saccharomyces/silicon ferment, saccharo - cosmetics

B BRAUN COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP 500mL bottle Australia - English - Department of Health (Therapeutic Goods Administration)

b braun compound sodium lactate intravenous infusion bp 500ml bottle

b braun australia pty ltd - sodium chloride, quantity: 6 mg/ml; calcium chloride dihydrate, quantity: 0.27 mg/ml; potassium chloride, quantity: 0.4 mg/ml; sodium lactate, quantity: 3.12 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solution may also be used as a solvent for intravenously administrated drugs where compatibility has been established. compound sodium lactate is particularly suitable for the replacement of extracellular fluid loss when isotonic dehydration is evident and in burn therapy.

BAXTER POTASSIUM CHLORIDE 40 mmol and 0.9% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 40 mmol and 0.9% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 29.8 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 10 mmol and 0.29% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 10 mmol and 0.29% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - sodium chloride, quantity: 2.92 g/l; potassium chloride, quantity: 7.46 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

B Braun 5% Glucose Intravenous Infusion BP 250 mL Bottle Australia - English - Department of Health (Therapeutic Goods Administration)

b braun 5% glucose intravenous infusion bp 250 ml bottle

b braun australia pty ltd - glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as solvents for intravenously administered drugs where compatibility has been established.

B Braun 5% Glucose Intravenous Infusion BP 100 mL Bottle Australia - English - Department of Health (Therapeutic Goods Administration)

b braun 5% glucose intravenous infusion bp 100 ml bottle

b braun australia pty ltd - glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as solvents for intravenously administered drugs where compatibility has been established.

B Braun 0.9% Sodium Chloride Intravenous Infusion BP 250 mL Bottle Australia - English - Department of Health (Therapeutic Goods Administration)

b braun 0.9% sodium chloride intravenous infusion bp 250 ml bottle

b braun australia pty ltd - sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as solvents for intravenously administered drugs where compatibility has been established. may also be used for irrigation of wounds and moistening of wound dressings.

B Braun 0.9% Sodium Chloride Intravenous Infusion BP 100mL Bottle Australia - English - Department of Health (Therapeutic Goods Administration)

b braun 0.9% sodium chloride intravenous infusion bp 100ml bottle

b braun australia pty ltd - sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as solvents for intravenously administered drugs where compatibility has been established. may also be used for irrigation of wounds and moistening of wound dressings.

TRINTELLIX- vortioxetine tablet, film coated United States - English - NLM (National Library of Medicine)

trintellix- vortioxetine tablet, film coated

takeda pharmaceuticals america, inc. - vortioxetine hydrobromide (unii: tks641koay) (vortioxetine - unii:3o2k1s3wqv) - vortioxetine 5 mg - trintellix is indicated for the treatment of major depressive disorder (mdd) in adults. - hypersensitivity to vortioxetine or any component of the formulation. hypersensitivity reactions including anaphylaxis, angioedema, and urticaria have been reported in patients treated with trintellix [see adverse reactions (6.2)] . - the use of maois intended to treat psychiatric disorders with trintellix or within 21 days of stopping treatment with trintellix is contraindicated because of an increased risk of serotonin syndrome. the use of trintellix within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated [see dosage and administration (2.4), warnings and precautions (5.2)] . starting trintellix in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome [see warnings and precautions (5.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monit

Intrarosa European Union - English - EMA (European Medicines Agency)

intrarosa

endoceutics s.a. - prasterone - postmenopause - other sex hormones and modulators of the genital system - intrarosa is indicated for the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms.,